Logo image of EBS

EMERGENT BIOSOLUTIONS INC (EBS) Stock Analyst Ratings

NYSE:EBS - New York Stock Exchange, Inc. - US29089Q1058 - Common Stock - Currency: USD

5.14  +0.22 (+4.47%)

After market: 5.06 -0.08 (-1.56%)

Buy % Consensus

74

ChartMill assigns a Buy % Consensus number of 74% to EBS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 13.77. This target is 167.9% above the current price.
EBS was analyzed by 7 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about EBS.
In the previous month the buy percentage consensus was at a similar level.
EBS was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

EBS Historical Analyst RatingsEBS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -101 -92 -83 -74 -65 -56 -47 -38 -29 -20 -11 -2 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 5.1412.1213.7713.7715.75 - 135.80% 167.90% 167.90% 206.42%

Related screens

EBS Current Analyst RatingEBS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-04-01 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-21 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-04 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-21 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-30 HC Wainwright & Co. Initiate Buy
2024-11-07 Benchmark Maintains Buy -> Buy
2024-09-13 Rodman & Renshaw Reiterate Buy -> Buy
2024-08-22 Rodman & Renshaw Initiate Buy
2024-08-16 Benchmark Reiterate Buy -> Buy
2024-08-09 Benchmark Reiterate Buy -> Buy
2024-07-03 Benchmark Reiterate Buy -> Buy
2024-07-02 Benchmark Reiterate Buy -> Buy
2024-06-24 Benchmark Reiterate Buy -> Buy
2024-06-21 Benchmark Reiterate Buy -> Buy
2024-06-20 Benchmark Maintains Buy -> Buy
2024-04-11 Benchmark Reiterate Buy -> Buy
2024-03-07 Benchmark Upgrade Hold -> Buy
2023-11-20 JP Morgan Reiterate Underweight
2023-08-29 Benchmark Downgrade Buy -> Hold
2023-05-31 Benchmark Reiterate Buy -> Buy
2023-05-19 Benchmark Reiterate Buy -> Buy
2023-04-10 Benchmark Upgrade Hold -> Buy
2023-03-17 JP Morgan Downgrade Neutral -> Underweight
2022-11-10 Benchmark Downgrade Buy -> Hold
2022-11-09 Chardan Capital Maintains Buy
2022-09-12 Cowen & Co. Maintains Market Perform
2022-05-04 Wells Fargo Maintains Equal-Weight
2022-04-29 Chardan Capital Maintains Buy
2022-03-10 Wells Fargo Maintains Equal-Weight